1-6 of 6
insurance claim review
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epidemiology and Real-World Treatment of Chronic Graft-Versus-Host Disease Post Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Carlos R. Bachier, MD, Sanjay K. Aggarwal, MD, Kalin Hennegan, MPH, Andrew Milgroom, Kevin Francis, Marcello Rotta, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2109.
https://doi.org/10.1182/blood-2019-130563
Published: 2019
Journal Articles

Out-of-Pocket (OOP) Costs Associated with Tyrosine Kinase Inhibitors (TKIs) Used for the Treatment of US Patients Diagnosed with Chronic Myeloid Leukemia (CML): A US Retrospective Claims Analysis

Ruth Kim, Deepa Malhotra, Timothy Bell, Fiona An, MD, Jack Mardekian
Journal: Blood
Blood (2017) 130 (Supplement 1): 2123.
https://doi.org/10.1182/blood.V130.Suppl_1.2123.2123
Published: 2017
Journal Articles

Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)

Sikander Ailawadhi, MD, Ryan D Frank, MS, Mayank Sharma, MBBS, Richa Menghani, MD, M'hamed Temkit, Shumail M. Paulus, MBBS, Nandita Khera, MD, Shahrukh K. Hashmi, MD, Pooja Advani, MBBS, Abhisek Swaika, MBBS, Aneel Paulus, MD, Nabeel Aslam, MD, Vivek Roy, MD, Gerardo Colon-Otero, MD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2016) 128 (22): 3544.
https://doi.org/10.1182/blood.V128.22.3544.3544
Published: 2016
Journal Articles

Acute Myeloid Leukemia (AML): A Retrospective Claims Analysis of Resource Utilization and Expenditures

William D Irish, PhD, Michael Ryan, MS, Larry Gache, Candace Gunnarsson, EdD, MA, Timothy Bell, Mark Shapiro
Journal: Blood
Blood (2015) 126 (23): 5633.
https://doi.org/10.1182/blood.V126.23.5633.5633
Published: 2015
Journal Articles

Pegfilgrastim Use Associated with Lower Risk of Hospitalization Than Filgrastim Use: A Retrospective US Claims Analysis.

Arash Naeim, MD, Henry J Henk, PhD, Laura Becker, MS, Victoria Chia, PhD, Sejal Badre, MS, Robert G Deeter, PharmD
Journal: Blood
Blood (2010) 116 (21): 3801.
https://doi.org/10.1182/blood.V116.21.3801.3801
Published: 2010
Journal Articles

Impact of Clinical/Demographic Characteristics and Duration of Clinical Benefit on Average Weekly Doses of Darbepoetin Alfa and Epoetin Alfa in Oncology: Results from a Claims Analysis.

Xue Song, PhD, Stacey R. Long, M.S., Joel D. Kallich, PhD, William D. Marder, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5538.
https://doi.org/10.1182/blood.V108.11.5538.5538
Published: 2006